Robust and transparent discussions between biomanufacturers and their suppliers are crucial to producing a strong forecast that both parties will find useful – never more so under the challenges of supply during Covid-19 and the increased demand on the in-bound supply chain. However, BioPhorum benchmarking exercises and surveys have highlighted that industry is often poor at forecasting and demand planning. For example, only around 50% of...
